Severe pulmonary toxicity in patients treated with a combination of docetaxel and gemcitabine for metastatic transitional cell carcinoma

Gemcitabine: metabolism, mechanisms of action, and self-potentiation.

William Plunkett, Peng Huang, Yi-Zheng Xu et al. · PubMed · 1995 · 756 citations

Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.

Scott Saxman, Kathleen J. Propert, Lawrence H. Einhorn et al. · Journal of Clinical Oncology · 1997 · 496 citations

Phase II study of gemcitabine in patients with advanced pancreatic cancer

J Carmichael, U. Fink, RC Russell et al. · British Journal of Cancer · 1996 · 370 citations · Full text

Urology, Pancreatic Cancer, Gastrointestinal Oncology +7

Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer.

Walter M. Stadler, Timothy M. Kuzel, Bruce J. Roth et al. · Journal of Clinical Oncology · 1997 · 346 citations

Metastatic Urothelial Cancer, Urology, Oncology +14

Advanced breast cancer: a phase II trial with gemcitabine.

J Carmichael, K. Possinger, P. Phillip et al. · Journal of Clinical Oncology · 1995 · 338 citations